 Double-blind evaluation efficacy tolerability metformin NIDDM OBJECTIVE efficacy tolerability metformin RESEARCH DESIGN AND METHODS double-blind placebo-controlled parallel-group trial University hospital diabetic clinics patients non-insulin-dependent diabetes NIDDM diet Metformin maximum dosage times RESULTS Mean SE metformin placebo Final mean blood glucose mM placebo biochemical variable change favorable glycemic response obese mean final dosage metformin CONCLUSIONS Metformin mean placebo weight gain significant unwanted effects